Upgrade to SI Premium - Free Trial

Eli Lilly & Co. (LLY) Reports RNAi Licensing & Research Collaboration with Dicerna Pharmaceuticals (DRNA)

October 29, 2018 6:13 AM
Eli Lilly and Company (NYSE: LLY) and Dicerna Pharmaceuticals (NASDAQ: DRNA) today announced a global licensing and research collaboration focused ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Management Comments

Next Articles